: Speakers

Speakers

05 – 06 May 2021 | BST (UTC+1)

Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.

The following are confirmed speakers for Gene Therapy EU: Online

Associate Director, Gene Editing Research and Development
Sarepta Therapeutics
Senior Medical Director
Sarepta Therapeutics
Senior Director, Regulatory Affairs
Sigilon Therapeutics
Vice President Global Regulatory Affairs
Sangamo Therapeutics
Team Leader, Gene Therapy, Advanced Drug Delivery, Pharmaceutical Sciences
AstraZeneca
George H. Kitzman Professor of Genetics, Chief, Division of Cellular and Molecular Therapy
University of Florida
Senior Vice President, Global Head of Medical Affairs
Dyne Therapeutics
Vice President, Translational Medicine
Asklepios BioPharmaceutical Inc
Chief Operating Officer
Sigilon Therapeutics
Associate Principal Scientist
AstraZeneca
Associate Director Analytical Sciences
Allergan
Vice President, Pharmaceutical Development
Ultragenyx Pharmaceutical
Senior Scientist - Cell & Gene Therapy
GammaDelta Therapeutics
Executive Director, Technical Operations, Gene Therapy
PTC Therapeutics
Head of Gene Therapy New Technologies & Innovation
Takeda
Chief Operating Officer
Asklepios BioPharmaceutical Inc
Chief Technology Officer
Mustang Bio
Senior Principal Scientist
Pfizer
Director Development Analytics and New Technologies
Roche
Vice President, US Commercial Head
Bluebird bio
Director, Vector Platform Research
Ultragenyx Pharmaceutical
Technology Manager
German Cancer Research Centre (DKFZ)
Associate Prinicipal Scientist
AstraZeneca
Associate Director, Genomic Medicine CMC
Sanofi
Senior Director, Health Economics and Outcomes Research (HEOR)
UniQure
Director Research & Discovery
Orchard Therapeutics
Vice President, Research and Development
Emendo Biotherapeutics
Associate Director - Gene Therapy
AstraZeneca
Associate Director of Human Cell & Disease Modeling
4D Molecular Therapeutics
Diagnostic Strategy Lead EMEA
Novartis
UK Chief Scientific Officer and Medical Director
Novartis
Senior Scientist, Gene Therapy Accelerator Unit (GTxAU)
Biogen
Chief Scientific Officer
Selecta Biosciences
President
British Society for Gene and Cell Therapy
Senior Principal Scientist
Pfizer
Executive Director, Nonclinical Disposition and Bioanalysis
Bristol-Myers Squibb
Executive Director, Vector Technologies
Autolus
Director, Downstream Process Development
Ultragenyx Pharmaceuticals

Download Brochure

Full details regarding Cell Series UK: Virtual are available for download in the Conference Brochure